Karolinska Development's portfolio company Modus Therapeutics raises capital to expand the development program for sevuparin

STOCKHOLM, SWEDEN November 8, 2023. Karolinska Development AB today announces that its portfolio company Modus Therapeutics has decided to carry out a rights issue that can raise up to approximately...

Related Keywords

Sweden ,Stockholm ,Karolinska Institutet ,Viktor Drvota ,Johan Dighed ,Karolinska Development Ab Nasdaq Stockholm ,Karolinska Development ,Nasdaq Stockholm ,Modus Therapeutics ,Nasdaq First North Growth Market ,Modus Therapeutic ,Volume Weighted Average Price ,General Counsel ,Markets ,